NCT00931528 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 112
- group Id
- BG001
- value
- 109
- group Id
- BG002
- value
- 221
- units
- Participants
- groups
- description
- Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil 5mg once daily for 24 weeks.
- id
- BG000
- title
- Tadalafil
- description
- Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 45
- upper Limit
- 80
- value
- 63
- group Id
- BG001
- lower Limit
- 48
- upper Limit
- 79
- value
- 63
- group Id
- BG002
- lower Limit
- 45
- upper Limit
- 80
- value
- 63
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 112
- group Id
- BG001
- value
- 109
- group Id
- BG002
- value
- 221
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- population Description
- All randomized eligible patients.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 112
- group Id
- BG001
- value
- 109
- group Id
- BG002
- value
- 221
- units
- Participants
- groups
- description
- Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil 5mg once daily for 24 weeks.
- id
- BG000
- title
- Tadalafil
- description
- Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 45
- upper Limit
- 80
- value
- 63
- group Id
- BG001
- lower Limit
- 48
- upper Limit
- 79
- value
- 63
- group Id
- BG002
- lower Limit
- 45
- upper Limit
- 80
- value
- 63
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 112
- group Id
- BG001
- value
- 109
- group Id
- BG002
- value
- 221
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- population Description
- All randomized eligible patients.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle